Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. none levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.9)]. there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of levetiracetam to femal

Malta - engleză - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics

Malta - engleză - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - levetiracetam - oral solution - levetiracetam 100 mg/ml - antiepileptics

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 1000 milligram(s) - levetiracetam

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 250 milligram(s) - levetiracetam

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 500 milligram(s) - levetiracetam

Australia - engleză - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: sodium chloride; sodium acetate trihydrate; glacial acetic acid; water for injections - levetiracetam concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.,levetiracetam concentrate solution for iv infusion is indicated for:,? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation.,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme).,? add on therapy in the treatment of primary generalised tonic-clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - oral solution - levetiracetam

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 500 milligram(s) - other antiepileptics; levetiracetam

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 1000 milligram(s) - other antiepileptics; levetiracetam